According to John Zhang, founder and CEO of the New Hope Fertility Center, universal PGS will likely increase success rates of IVF further.
A study by researchers in Italy found that preimplantation genetic diagnosis and screening combined led to more successful pregnancies per transfer but fewer women had embryos transferred.
The genetic diagnostics firm has developed an NGS-based test that combines PGS, PGD, and informativity testing, and presented initial results at a recent conference.
The team built on a previous approach that used single-cell sequencing to screen for chromosomal abnormalities in embryos from couples undergoing IVF.
The firm plans to incorporate mtDNA analysis into its preimplantation genetic screening services this month.
The method could have future applications in preimplantation genetic diagnosis and circulating tumor cell analysis.
RHS recently acquired an Arrayjet Marathon instrument to produce EmbryoCellect, which competes with PGS kits sold by Illumina, Agilent Technologies, OGT, and others.
The company's goal is to transition from a one-test provider to a full-service genetic testing company in the reproductive health and potentially other markets.
The FAST-SeqS test screens embryos for chromosomal aneuploidies prior to implantation in an in vitro fertilization setting.
NEW YORK (GenomeWeb) – Illumina has launched its VeriSeq test for preimplantation genetic screening on the MiSeq platform, the company said this week.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.